Evidence map›Paper›PMID 33780290›Full record

ReviewAnnals of internal medicine2021

Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19.

Andrea M Lerner, Daphne A Robinson, Linda Yang, Carolyn F Williams, Lori M Newman, Joseph J Breen, Robert W Eisinger, Johanna S Schneider, Adaora A Adimora, Emily J Erbelding

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. "Healing Can Be a Very Jagged Line": Reflections on Life as a COVID-19 Long Hauler.Journal of patient-centered research and reviews · 2023
    Article
  16. Article
  17. Effects of Aerobic Training in Patients with Subacute COVID-19: A Randomized Controlled Feasibility Trial.International journal of environmental research and public health · 2022
    Article
  18. Post-Viral Fatigue Following SARS-CoV-2 Infection during Pregnancy: A Longitudinal Comparative Study.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea M LernerNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
Daphne A RobinsonNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).ORCID 0000-0002-8817-6937
Linda YangNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
Carolyn F WilliamsNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).ORCID 0000-0002-5667-486X
Lori M NewmanNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
Joseph J BreenNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
Robert W EisingerNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).ORCID 0000-0002-0006-8772
Johanna S SchneiderNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
Adaora A AdimoraThe University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (A.A.A.).ORCID 0000-0001-5035-1552
Emily J ErbeldingNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past year, the SARS-CoV-2 pandemic has swept the globe, resulting in an enormous worldwide burden of infection and mortality. However, the additional toll resulting from long-term consequences of the pandemic has yet to be tallied. Heterogeneous disease manifestations and syndromes are now recognized among some persons after their initial recovery from SARS-CoV-2 infection, representing in the broadest sense a failure to return to a baseline state of health after acute SARS-CoV-2 infection. On 3 to 4 December 2020, the National Institute of Allergy and Infectious Diseases, in collaboration with other Institutes and Centers of the National Institutes of Health, convened a virtual workshop to summarize existing knowledge on postacute COVID-19 and to identify key knowledge gaps regarding this condition.

Indexed as

National Institutes of Health (U.S.)PandemicsSARS-CoV-2COVID-19HumansUnited States

Identifiers

PMID33780290
PMCPMC8025940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.